Filing Details

SEC Filing Details

Document Details

Filing Date
Oct 17, 2018
Document Date
Oct 17, 2018
Form Description
Registration of up to an additional 20% of securities for any offering registered on a S-3
Filing Group
Registration Statements
Company
Aclaris Therapeutics, Inc.
Issuer
Aclaris Therapeutics, Inc